Si Meijun, Fu Jingpeng, Fang Mengting, Lu Yunfei, Huang Junxuan, Li Haojie, Wang Peiyi, Liao Maofu, Zhu Jian, Li Peiyao, Zhong Wenzhao, Guo Zhifei, Yang Wei, Ye Zhiming, Hu Hongli, Yu Xueqing
Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Guangdong-Hong Kong Joint Laboratory on Immunological and Genetic Kidney Diseases, Guangzhou, China.
Nat Commun. 2025 Jul 1;16(1):5536. doi: 10.1038/s41467-025-60819-w.
The retention of galactose-deficient IgA1 (Gd-IgA1) in the mesangium is central to IgA nephropathy (IgAN), but its intracellular fate remains unclear. Here, we show that transferrin receptor 1 (TfR1) mediates Gd-IgA1 uptake into mesangial cell lysosomes, where it forms non-digestible aggregates, disrupts lysosomal function, and triggers inflammatory responses. In renal biopsies from IgAN patients, IgA1 aggregates co-localize with TfR1 within lysosomes. In male mice, TfR1 overexpression enhanced lysosomal accumulation of Gd-IgA1, whereas TfR1 knockdown reduced it. Mechanistically, acidic pH strengthens TfR1-Gd-IgA1 binding via the galactose-deficient hinge region and residue R276. While we acknowledge that sialylation commonly found in patient-derived IgA1 might influence TfR1 binding and that other receptors, such as ASGPR, were not evaluated, our findings nonetheless reveal a lysosome-centered mechanism in IgAN and highlight receptor-mediated retention of Gd-IgA1 as a potential therapeutic target.
半乳糖缺陷型IgA1(Gd-IgA1)在系膜中的潴留是IgA肾病(IgAN)的核心,但它在细胞内的命运仍不清楚。在这里,我们表明转铁蛋白受体1(TfR1)介导Gd-IgA1摄取进入系膜细胞溶酶体,在那里它形成不可消化的聚集体,破坏溶酶体功能,并引发炎症反应。在IgAN患者的肾活检中,IgA1聚集体与溶酶体内的TfR1共定位。在雄性小鼠中,TfR1过表达增强了Gd-IgA1在溶酶体中的积累,而TfR1敲低则减少了这种积累。从机制上讲,酸性pH通过半乳糖缺陷型铰链区和残基R276增强TfR1与Gd-IgA1的结合。虽然我们承认患者来源的IgA1中常见的唾液酸化可能影响TfR1结合,并且未评估其他受体,如去唾液酸糖蛋白受体(ASGPR),但我们的研究结果仍然揭示了IgAN中以溶酶体为中心的机制,并强调受体介导的Gd-IgA1潴留作为一个潜在的治疗靶点。